![5-{2-amino-1-[4-(morpholin-4-yl)phenyl]-1H-benzimidazol-6-yl}-N-(2-fluorophenyl)-2-methoxypyridine-3-sulfonamide in PDB entry 6bq1, assembly 1, side view.](https://www.ebi.ac.uk/pdbe/static/entry/6bq1_entity_5_side_image-200x200.png "Hetero hexameric assembly 1 of PDB entry <span class='highlight'>6bq1</span> contains 2 copies of <span class='highlight'>5-{2-amino-1-[4-(morpholin-4-yl)phenyl]-1H-benzimidazol-6-yl}-N-(2-fluorophenyl)-2-methoxypyridine-3-sulfonamide</span>. Side view.")
![5-{2-amino-1-[4-(morpholin-4-yl)phenyl]-1H-benzimidazol-6-yl}-N-(2-fluorophenyl)-2-methoxypyridine-3-sulfonamide in PDB entry 6bq1, assembly 1, top view.](https://www.ebi.ac.uk/pdbe/static/entry/6bq1_entity_5_top_image-200x200.png "Hetero hexameric assembly 1 of PDB entry <span class='highlight'>6bq1</span> contains 2 copies of <span class='highlight'>5-{2-amino-1-[4-(morpholin-4-yl)phenyl]-1H-benzimidazol-6-yl}-N-(2-fluorophenyl)-2-methoxypyridine-3-sulfonamide</span>. Top view.")
Environment details NEW
E4S 2201 bound to chain A
The above 2D and 3D (Mol*) views of ligand interactions use quaternary structure derived from the PDB entry.
Please note:
Please note:
- Some chain IDs in the tooltip are followed by a number in square brackets. This number corresponds to the operation ID (mmCIF ‘oper_expression’) used to transform the chain.
- The structure seen in Mol* (3D view) was protonated using ChimeraX.
- Interactions were calculated using Arpeggio (see details for interaction types).
- The colour scheme used is consistent with Clustal X.